Reading this on a mobile device? Try our optimized mobile version here:

November 7, 2012News for the transfusion medicine and cellular therapy community

  Top Story 
  • IPad optical scanner helps measure blood loss during surgery
    Researchers at Stanford University School of Medicine have developed an optical scanner for Apple's iPad tablet computer that can help accurately measure blood loss during surgery. Researchers said that based on confirmation tests using spectrophotometry, the algorithm reduced variability in measuring blood loss compared with standard human visual estimates and performed well with high blood volumes. A startup company called Gauss Surgical is working to further develop the test, with the aim of putting it in the clinical setting late this year or early next year. Anesthesiology News (free registration) (11/2012) LinkedInFacebookTwitterEmail this Story
The Eleventh Cell in Immucor Panocell-10
Immucor's panels offer a cost-effective means to identify a single antibody or the ability to distinguish between multiple antibodies. The Panocell®-10 has an eleventh cell, the "Techcell", that represents unusual phenotypes such as I neg or Co(a-). To learn more about the Panocell®-10, call us at 855-IMMUCOR or visit our website.

  Science & Health 
  • Researchers find potential biomarkers for organ rejection
    Researchers at the California Pacific Medical Center in San Francisco have discovered a set of five genetic markers in the blood of patients who experienced rejection of a transplanted kidney. The researchers assessed blood samples from 236 kidney transplant recipients and then conducted biopsies to determine rejection, according to the study published in the American Journal of Transplantation. More studies need to be conducted before blood tests can be used in place of biopsies in diagnosing organ rejection, said the researchers. San Francisco Chronicle (11/6) LinkedInFacebookTwitterEmail this Story
  • Standard anticoagulant dose not right for all patients
    Most patients taking the anticoagulants clopidogrel and prasugrel at standard doses may not be getting the right dose for themselves, according to a study presented at a heart association meeting. For both drugs, only a quarter of patients were getting the proper dose. Researchers said a blood test to determine whether blood is clotting properly may help in the development of individualized dosing. HealthDay News (11/6) LinkedInFacebookTwitterEmail this Story
  • U.K. groups to develop iPS cell database
    The U.K.'s Medical Research Council and the Wellcome Trust will put $20.5 million toward the development of a database of induced pluripotent stem cells, to be called the Human Induced Pluripotent Stem Cell Initiative. The initiative will aim to produce iPS cells from healthy volunteers and from patient groups for use in genetic disease studies. The database will function as a "comprehensive resource for investigating how genetic variation impacts on cell behavior and how diseases linked to a specific genetic defect can result in a broad spectrum of clinical abnormalities," according to the Wellcome Trust. GenomeWeb Daily News (free registration) (11/6) LinkedInFacebookTwitterEmail this Story
  • Storm flooding, blackouts imperil research
    A power outage and flooding at NYU Langone Medical Center threatened years of research as biological samples were left in thawing freezers and warming refrigerators and animals drowned in basements. An estimated 10,000 laboratory rodents that drowned at the Smilow Research Center had been genetically altered for research on heart disease, cancer, epigenetics and mental disorders. Scientists at other research centers said they will donate animals to restart some research programs. The New York Times (tiered subscription model) (10/31), ABC News/"Good Morning America" (10/31) LinkedInFacebookTwitterEmail this Story
Want More CME/CE Credit from AABB?
Now it's even easier to accomplish your training needs and earn CME/CE credits. Convenient and accessible anytime, the AABB Live Learning Center offers quick access to essential Annual Meeting and audioconference content. Most products offer CME/CE tracking and attendance certification. Click here to get started!

  Emerging Trends 
  • Report lists 10 biggest perils tied to health tech in 2013
    The ECRI Institute has issued a report detailing its list of the 10 key health technology hazards for 2013, including mismatches of patient records in health IT systems and failed interoperability involving HIT tools and medical devices. Given these potential risks, the report urges health groups to put a greater focus on HIT when planning safety efforts for next year. Health Data Management (11/5) LinkedInFacebookTwitterEmail this Story
Call for Tenders
The Australian Red Cross Blood Service wishes to advise providers of Floor Standing Blood Bag Centrifuges of a call for tender. To receive more details, prospective suppliers should email by 2.00pm AEDT Friday 9 November 2012. All tenders must be received by 2.00pm AEDT Friday 14 December 2012.

  Industry News & Practice 
  • Companies aim to secure contracts for defense threat reduction
    PositiveID has entered a deal with Science Applications International Corp. with the aim of securing defense contracts focused on threat reduction. The deal will combine SAIC's system engineering and integration technologies with PositiveID's Dragonfly Rapid MD-x Cartridge-based diagnostic system and Microfluidics-based Bioagent Networked Detector. DragonFly is being developed as a tool to help identify influenza strains and other pathogens, including methicillin-resistant Staphylococcus aureus, as well as cell damage from radiation. GenomeWeb Daily News (free registration) (11/6) LinkedInFacebookTwitterEmail this Story
  Government & Regulatory 
  • Paragonix seeks 510(k) clearance for cardiac transport device
    Paragonix Technologies has filed an application with the FDA seeking 510(k) clearance for the Sherpa Pak Cardiac Transport System. The disposable device, which is used to store donor hearts in transit, releases oxygenated blood to organs and is designed to extend the preservation time for donor hearts from the current four hours to 12 hours. Mass High Tech (Boston) (11/6) LinkedInFacebookTwitterEmail this Story
  Association News 
  • Reminder: AABB Seeks Input for 2013 Annual Meeting Educational Program
    Individuals are encouraged to submit education session proposals for the upcoming 2013 AABB Annual Meeting and CTTXPO in Denver. Proposals should be for 90-minute and three-hour programs focused on cellular therapies, patient blood management, leadership management, quality education, scientific issues and technical/clinical issues. The deadline for submissions is Nov. 16. Questions may be directed to AABB's Education and Professional Development department. LinkedInFacebookTwitterEmail this Story
Learn more about AABB® ->Homepage  |  Join AABB  |  Conferences  |  Marketplace

Position TitleCompany NameLocation
West Coast Account ManagerMacopharma USAUS - Nationwide
Director, LaboratorySan Diego Blood BankUS - CA - San Diego
VP Patient ServicesBlood Centers of the PacificUS - CA - San Francisco
Director, Patient Blood ManagementAABBUS - MD - Bethesda
Quality Source ConsultantBlood Systems, Inc.US - Nationwide
Quality SpecialistBlood Systems, Inc.US - NM - Albuquerque
Immunohematology Reference TechnologistLifeStreamUS - CA - San Bernardino
Help Desk SpecialistAABBUS - MD
Director, Operational Policies and Procedures (Corporate Donor Recruitment)Blood Systems, Inc.US - AZ - Scottsdale
Staff AccountantAABBUS - MD
Marketing Manager, Cellular TherapiesAABBUS - MD
Click here to view more job listings.

Success is often just an idea away."
--Frank Tyger,
American cartoonist, columnist and humorist

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Corporate Relations Manager:  Tamara Zein (240) 333-6604
Job Board: AABB CareerLink
A powerful website for SmartBrief readers including:
 Recent AABB SmartBrief Issues:   Lead Editor:  Tom Parks
Managing Editor: Cristian Becker

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2012 SmartBrief, Inc.® Legal Information